Getting to Market
A Discussion on Challenges, Opportunities and Market Access within Advanced Therapies; how do we create a robust market economy for Advanced therapies, taking into account costs of goods, manufacture and procurement. Do we need a new business model?
FACILITATED BY
MARTINO PICARDO | Chairman | Discovery Park
PANELLISTS INCLUDE
KATE COLEMAN | Senior Director and Principal Consultant | PharmaLex
KEITH FOSTER | Chief Science Officer | Sutura Therapeutics
KATE ROWLEY | Venture Partner | Global Bio Fund